tiprankstipranks
Immunic (IMUX)
NASDAQ:IMUX
US Market
IMUX
Immunic
RESEARCH TOOLSreports

Immunic (IMUX) Income Statement

2,214 Followers

Immunic Income Statement

Last quarter (Q4 2025), Immunic's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Immunic's net income was $-19.30M. See Immunic’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -168.00K$ 0.00$ -111.00K$ 0.00$ 0.00
Operating Expenses
$ 103.23M$ 98.05M$ 99.22M$ 119.49M$ 91.67M
Depreciation and Amortization
$ 168.00K$ 134.00K$ 111.00K$ 77.00K$ 85.00K
EBITDA
$ -97.00M$ -97.92M$ -99.11M$ -86.44M$ -91.58M
Operating Income
$ -103.23M$ -98.05M$ -99.22M$ -119.49M$ -91.67M
Other Income/Expenses
$ 6.06M$ -2.46M$ 5.61M$ -919.00K$ -1.28M
Pretax Income
$ -97.17M$ -100.51M$ -93.61M$ -120.41M$ -92.94M
Net Income
$ -97.17M$ -100.51M$ -93.61M$ -120.41M$ -92.94M
Per Share Metrics
Basic EPS
$ -0.62$ -1.00$ -2.11$ -3.78$ -3.92
Diluted EPS
$ -0.62$ -1.00$ -2.11$ -3.78$ -3.92
Weighted Average Shares Outstanding
 1.56B 100.17M 44.32M 31.82M 23.65M
Weighted Average Shares Outstanding (Diluted)
 1.56B 100.17M 44.32M 31.82M 23.65M
Currency in USD

Immunic Earnings and Revenue History